<DOC>
	<DOCNO>NCT01736254</DOCNO>
	<brief_summary>The purpose study measure much study drug ( evacetrapib ) get blood stream long take body get rid give gemfibrozil . Each participant receive gemfibrozil alone , evacetrapib alone , drug combination . There washout period dos . The safety study drug give together evaluate . Information side effect may occur also collect . This study last approximately 36 day .</brief_summary>
	<brief_title>A Study Evacetrapib Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Evacetrapib</mesh_term>
	<mesh_term>Gemfibrozil</mesh_term>
	<criteria>Healthy participant determine medical history physical examination Have body mass index 18 32 kilogram per square meter ( kg/m^2 ) Have know allergy evacetrapib gemfibrozil , related compound component formulation Have abnormality 12lead electrocardiogram ( ECG ) , opinion investigator , increase risk associate participate study Regularly use know drug abuse and/or show positive finding urinary drug screen Currently smoke cigarette use tobacco nicotine substitute</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>